Ebisuno Yukihiko, Tanaka Toshiyuki, Kanemitsu Naotoshi, Kanda Hidenobu, Yamaguchi Kazuhito, Kaisho Tsuneyasu, Akira Shizuo, Miyasaka Masayuki
Laboratory of Molecular and Cellular Recognition, Osaka University Graduate School of Medicine, Suita, Japan.
J Immunol. 2003 Aug 15;171(4):1642-6. doi: 10.4049/jimmunol.171.4.1642.
While CCR7 ligands direct T cell trafficking into lymph nodes (LNs) and Peyer's patches (PPs), chemokines that regulate B cell trafficking across high endothelial venules (HEVs) remain to be fully elucidated. Here we report that CXC chemokine ligand (CXCL)13 (B lymphocyte chemoattractant) is detected immunohistologically in the majority of HEVs in LNs and PPs of nonimmunized mice. Systemically administered anti-CXCL13 Ab bound to the surface of approximately 50% of HEVs in LNs and PPs, but not to other types of blood vessels, indicating that CXCL13 is expressed in the HEV lumen. In CXCL13-null mice, B cells rarely adhered to PP HEVs, whereas T cells did efficiently. Superfusion of CXCL13-null PPs with CXCL13 restored the luminal presentation of CXCL13 and also B cell arrest in PP HEVs at least partially. Collectively, these results indicate that CXCL13 expressed in the HEV lumen plays a crucial role in B cell trafficking into secondary lymphoid tissues such as PPs.
虽然CCR7配体引导T细胞迁移至淋巴结(LN)和派尔集合淋巴结(PP),但调节B细胞跨高内皮微静脉(HEV)迁移的趋化因子仍有待充分阐明。在此,我们报告在未免疫小鼠的LN和PP的大多数HEV中,通过免疫组织学检测到CXC趋化因子配体(CXCL)13(B淋巴细胞趋化因子)。全身注射抗CXCL13抗体可结合到LN和PP中约50%的HEV表面,但不结合其他类型的血管,表明CXCL13在HEV管腔中表达。在CXCL13基因敲除小鼠中,B细胞很少黏附于PP的HEV,而T细胞则能有效黏附。用CXCL13对CXCL13基因敲除的PP进行灌流,可恢复CXCL13在管腔中的呈现,并且至少部分恢复了B细胞在PP的HEV中的滞留。总体而言,这些结果表明在HEV管腔中表达的CXCL13在B细胞迁移至诸如PP等二级淋巴组织中起关键作用。